Giuseppe Crescenzi

A Meta-analysis of Randomized Clinical Trials

Giuseppe Crescenzi, Giovanni Landoni, Giuseppe Biondi‐Zoccai et al. · 2008 · 181 citations

Blood Loss, Pharmacotherapy, Blood Product Transfusion +23

EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count

Stefania Paolucci, Irene Cassaniti, Federica Novazzi et al. · International Journal of Infectious Diseases · 2020 · 111 citations · Full text

Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: A one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors

Giuseppe Derosa, Amedeo Mugellini, Leonardina Ciccarelli et al. · Clinical Therapeutics · 2003 · 76 citations

Obesity, Metabolic Syndrome, Hypertension +12

Comparison of glycaemic control and cardiovascular risk profile in patients with type 2 diabetes during treatment with either repaglinide or metformin

Giuseppe Derosa, Amedeo Mugellini, Leonardina Ciccarelli et al. · Diabetes Research and Clinical Practice · 2003 · 56 citations

Metabolic Syndrome, Diabetes Management, Health Policy +8

QTc Interval and Mortality in a Population of SARS-2-CoV Infected Patients

Alessandro Vicentini, Lucrezia Masiello, Sabato D’Amore et al. · Circulation Arrhythmia and Electrophysiology · 2020 · 11 citations · Full text

Viral Persistence, Virus Epidemiology, Qtc Interval +8